Evidence map›Paper›PMID 35937701›Full record

ArticleFrontiers in cellular and infection microbiology2022

LewisOscar Felix, Biswajit Mishra, Rajamohammed Khader, Narchonai Ganesan, Eleftherios Mylonakis

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.8field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 31 citations in OpenAlex.

  1. α-Mangostin attenuatesVirulence · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Antimicrobial activity of α-mangostin againstFrontiers in cellular and infection microbiology · 2023
    Article
  18. Mechanism of Synergy between Piceatannol and Ciprofloxacin againstInternational journal of molecular sciences · 2022
    Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

LewisOscar FelixInfectious Diseases Division, Alpert Medical School of Brown University, Providence, RI, United States.
Biswajit MishraInfectious Diseases Division, Alpert Medical School of Brown University, Providence, RI, United States.
Rajamohammed KhaderInfectious Diseases Division, Alpert Medical School of Brown University, Providence, RI, United States.
Narchonai GanesanInfectious Diseases Division, Alpert Medical School of Brown University, Providence, RI, United States.
Eleftherios MylonakisInfectious Diseases Division, Alpert Medical School of Brown University, Providence, RI, United States.
Brown University · US

Funding

Technical Mother Machine CoreP01AI083214 · NIAID · SCHEPENS EYE RESEARCH INSTITUTE · PI David C Hooper · 2009 to 2026
$39.4M
Using Genomic Epidemiology to Identify Transmission Patterns and Inform Intervention Strategies for Antibiotic-Resistant N. GonorrhoeaeP20GM121344 · NIGMS · MIRIAM HOSPITAL · PI D'AGATA, ERIKA M · 2018 to 2022
$9.4M
NIAID NIH HHS P01 AI083214NIGMS NIH HHS P20 GM121344
6 · The paper itself

Abstract

The formation of persister cells is associated with recalcitrance and infections. In this study, we examined the antimicrobial property of alpha mangostin, a natural xanthone molecule, against methicillin-resistant

Indexed as

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsXanthonesAnti-Bacterial AgentsBiofilmsHumansMicrobial Sensitivity TestsStaphylococcus aureusAnti-Bacterial AgentsmangostinXanthonesalpha mangostinbiofilmGalleria mellonellapersistersStaphylococcus aureus

Identifiers

PMID35937701
PMCPMC9353584
OpenAlexW4286471637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.